# Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia

> **NCT00939341** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 862 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Symbicort (Budesonide/Formoterol)

## Key facts

- **NCT ID:** NCT00939341
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 862 (ACTUAL)
- **Last updated:** 2012-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00939341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00939341, "Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00939341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*